AxoGen, Inc.
AXGN
Rank in Stocks
#4641
AxoGen, Inc., along with its subsidiaries, specializes in creating and... AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating the gentle reconnection of severed peripheral nerves, the company offers the AxoGuard Nerve Connector, an extracellular matrix (ECM) derived from porcine submucosa. This same porcine submucosa ECM forms the basis of the AxoGuard Nerve Protector, which is utilized to encase and safeguard damaged peripheral nerves, supporting their reconstruction and preventing unwanted adhesions from surrounding soft tissues. Another ECM product, the AxoGuard Nerve Cap, isolates the nerve end from its environment to help mitigate the formation of painful neuromas. Furthermore, AxoGen provides the Avive Soft Tissue Membrane, a processed human umbilical cord membrane that functions as an absorbable covering for soft tissues, used to separate tissues within the surgical area. An additional tool available is the AxoTouch two-point discriminator, used for evaluating the density of nerve innervation on the skin's surface. These products are supplied to hospitals, surgery centers, and military medical facilities, catering to plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen's market reach extends across the United States, Canada, Germany, the United Kingdom, other European nations, South Korea, and internationally. The company's main operations are situated in Alachua, Florida.
Share Price
$50.64
Last synced: 2026-11-09
Market Cap
$3.02B
Change (1 day)
1.24%
Change (1 year)
107.03%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade AxoGen, Inc. (AXGN)
Category
Healthcare
EPS for AxoGen, Inc. (AXGN)
EPS as of September 2026 TTM: $-0.65
According to AxoGen, Inc.'s latest financial reports, its current EPS (TTM) is $-0.65. At the end of 2025 the company had an EPS of $-0.34, a decrease compared to its 2024 EPS of $-0.23.
EPS history for AxoGen, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.65 | 91.18% |
| 2025 | $-0.34 | 47.83% |
| 2024 | $-0.23 | -54.90% |
| 2023 | $-0.51 | -26.09% |
| 2022 | $-0.69 | 6.15% |
| 2021 | $-0.65 | 8.33% |
| 2020 | $-0.60 | -18.92% |
| 2019 | $-0.74 | 23.33% |
| 2018 | $-0.60 | 93.55% |
| 2017 | $-0.31 | -34.04% |
| 2016 | $-0.47 | -7.84% |
| 2015 | $-0.51 | -49.00% |
| 2014 | $-1.00 | -7.41% |
| 2013 | $-1.08 | 27.06% |
| 2012 | $-0.85 | -65.86% |
| 2011 | $-2.49 | 703.23% |
| 2010 | $-0.31 | -108.83% |
| 2009 | $3.51 | -1,562.50% |
| 2008 | $-0.24 | 33.33% |
| 2007 | $-0.18 | 103.39% |
| 2006 | $-0.09 | -31.92% |
| 2005 | $-0.13 | -122.81% |
| 2004 | $0.57 | -278.13% |
| 2003 | $-0.32 | -51.52% |
| 2002 | $-0.66 | -294.12% |
| 2001 | $0.34 | -145.95% |
| 2000 | $-0.74 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -515.38% |
US
|
|
| $4.09 | -729.23% |
IE
|
|
| $9.45 | -1,553.85% |
US
|
|
| $2.37 | -464.62% |
US
|
|
| $1.77 | -372.31% |
US
|
Questions about AxoGen, Inc.'s earnings per share (EPS)
What is AxoGen, Inc.'s earnings per share (EPS)?
AxoGen, Inc.'s earnings per share (EPS) over the last twelve months is $-0.65, as of Sep 2026.
What was AxoGen, Inc.'s earnings per share (EPS) in 2025?
In 2025, AxoGen, Inc.'s earnings per share (EPS) was $-0.34, compared with $-0.23 in 2024.
How has AxoGen, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, AxoGen, Inc.'s earnings per share (EPS) was highest in 2024 ($-0.23) and lowest in 2022 ($-0.69).
How does AxoGen, Inc.'s earnings per share (EPS) compare with similar companies?
AxoGen, Inc.'s earnings per share (EPS) ($-0.65) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.